Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Stephenson, J
Right arrow Articles by Gilbert, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephenson, J
Right arrow Articles by Gilbert, J
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The development of clinical guidelines on paracentesis for ascites related to malignancy

J Stephenson

Derriford Hospital and St. Luke's Hospice, Plymouth

J Gilbert

Exeter and District Hospice and Royal Devon and Exeter Hospital, Exeter

Malignancy-related ascites gives rise to troublesome symptoms and carries a poor prognosis. Abdominal paracentesis is a widely used and effective procedure for symptom relief, but practice with regard to the procedure itself may vary considerably. Evidence obtained in the context of liver disease probably influences practice in malignancy, although the pathophysiology involved is different. Anecdotal evidence suggested a difference in practice between the Exeter and District Hospice and the adjoining hospital, and this was confirmed by a review of case notes. Patients undergoing paracentesis in the hospital were more likely to have prior ultrasound assessment and to be given intravenous fluids, and had longer drainage times and longer inpatient stays. It seemed that some practices were placing unnecessary burdens on patients whose life expectancy was short. A set of clinical guidelines for the procedure was drawn up, based on the limited evidence available and the practice within the hospice. These guidelines emphasise performing ultrasound investigations only in cases of diagnostic uncertainty, allowing up to 5 L of fluid to drain without clamping, leaving drains in for no more than 6 h and giving intravenous fluids only when specifically indicated. These guidelines were introduced on the oncology ward of the adjoining hospital. The impact on practice was assessed by means of a retrospective case note review of all procedures carried out on the ward in the 6 months before and after the guidelines were introduced. The introduction of guidelines resulted in significant reductions in prior ultrasound assessment, mean length of time drains were left in and mean length of inpatient stay for planned procedures. There were no cases of symptomatic hypotension in the postguidelines group.

Key Words: ascites • guidelines • malignancy • paracentesis • palliative care

Palliative Medicine, Vol. 16, No. 3, 213-218 (2002)
DOI: 10.1191/0269216302pm509oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
P. WIMBERGER, M. HEUBNER, H. LINDHOFER, M. JAGER, R. KIMMIG, and S. KASIMIR-BAUER
Influence of Catumaxomab on Tumor Cells in Bone Marrow and Blood in Ovarian Cancer
Anticancer Res, May 1, 2009; 29(5): 1787 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Burges, P. Wimberger, C. Kumper, V. Gorbounova, H. Sommer, B. Schmalfeldt, J. Pfisterer, M. Lichinitser, A. Makhson, V. Moiseyenko, et al.
Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM x Anti-CD3 Antibody: A Phase I/II Study
Clin. Cancer Res., July 1, 2007; 13(13): 3899 - 3905.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
A. Lee and L. T. Neng
Letter to the Editor
Palliative Medicine, June 1, 2003; 17(4): 378 - 378.
[PDF]


Home page
Palliat MedHome page
J. Stephenson and J. Gilbert
A reply
Palliative Medicine, June 1, 2003; 17(4): 379 - 379.
[PDF]